Abstract:The "sphingosin" backbone of sphingolipids was so named by J. L. W. Thudichum in 1884 for its enigmatic ("Sphinx-like") properties. Although still an elusive class of lipids, research on the involvement of sphingolipids in the signal transduction pathways that mediate cell growth, differentiation, multiple cell functions, and cell death has been rapidly expanding our understanding of these compounds. In addition to the newly discovered role of ceramide as an intracellular second messenger for tumor necrosis factor-alpha, IL-1beta, and other cytokines, sphingosine, sphingosine-1-phosphate, and other sphingolipid metabolites have recently been demonstrated to modulate cellular calcium homeostasis and cell proliferation. Perturbation of sphingolipid metabolism using synthetic and naturally occurring inhibitors of key enzymes of the biosynthetic pathways is aiding the characterization of these processes; for examples, inhibition of cerebroside synthase has indicated a role for ceramide in cellular stress responses including heat shock, and inhibition of ceramide synthase (by fumonisins) has revealed the role of disruption of sphingolipid metabolism in several animal diseases. Fumonisins are currently the focus of a FDA long-term tumor study. This review summarizes recent research on (i) the role of sphingolipids as important components of the diet, (ii) the role of sphingoid base metabolites and the ceramide cycle in expression of genes regulating cell growth, differentiation, and apoptosis, (iii) the use of cerebroside synthase inhibitors as tools for understanding the role of sphingolipids as mediators of cell cycle progression, renal disease, and stress responses, and (iv) the involvement of disrupted sphingolipid metabolism in animal disease and cellular deregulation associated with exposure to inhibitors of ceramide synthase and serine palmitoyltransferase, key enzymes in de novo sphingolipid biosynthesis. These findings illustrate how an understanding of the function of sphingolipids can help solve questions in toxicology and this is undoubtedly only the beginning of this story.

Emerging biology of sphingosine-1-phosphate: its role in pathogenesis and therapy.

Sphingosine 1-phosphate: Lipid signaling in pathology and therapy

Point-Counterpoint of Sphingosine 1-Phosphate Metabolism

Sphingosine 1-phosphate and inflammation.

Modulation of protein kinase C and diverse cell functions by sphingosine--a pharmacologically interesting compound linking sphingolipids and signal transduction

Sphingosine-1-phosphate Signaling Pathway: a Novel Therapeutic Target for Cardiovascular Diseases

Regulation of cellular and systemic sphingolipid homeostasis

Explore the Role of the Sphingosine-1-Phosphate Signalling as a Novel Promising Therapeutic Target for the Management of Parkinson's Disease

Sphingosine 1-phosphate receptor, a new therapeutic direction in different diseases

Sphingosine-1-phosphate: a Potential Therapeutic Target for Rheumatoid Arthritis

The Current Landscape in the Development of Small-molecule Modulators Targeting Sphingosine-1-phosphate Receptors to Treat Neurodegenerative Diseases

Principles of bioactive lipid signalling: lessons from sphingolipids

Sphingolipids and their metabolism in physiology and disease

A Comprehensive Review: Sphingolipid Metabolism and Implications of Disruption in Sphingolipid Homeostasis

A Pipeline to Investigate the Structures and Signaling Pathways of Sphingosine 1-Phosphate Receptors

Sphingosine 1-phosphate, a key mediator of the cytokine network: juxtacrine signaling.

Sphingolipids--the enigmatic lipid class: biochemistry, physiology, and pathophysiology

Sphingosine‐1‐phosphate receptors and innate immunity

Sphingosine 1-phosphate and its regulatory role in vascular endothelial cells

An overview of sphingosine‐1‐phosphate receptor 2: Structure, biological function, and small‐molecule modulators

Molecular basis of Spns2-facilitated sphingosine-1-phosphate transport